Neil Woodford just snapped up a bargain stock you’ve probably never heard of

Neil Woodford’s new stock buy could be a great addition to your portfolio, says G A Chester.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Renowned fund manager Neil Woodford is well known for his big investments in blue-chip companies. FTSE 100 giants in the pharma and tobacco sectors — AstraZeneca, Imperial Brands, British American Tobacco and GlaxoSmithKline — are the top holdings in his flagship equity income fund.

However, he’s certainly not averse to looking for stocks outside the mega-caps. Indeed, the market was notified this week that he’s bought a £70m stake in a business that many readers have probably never heard of. The company in question only joined the stock market this time last year and is listed in the FTSE SmallCap index.

However, like Woodford, I’m not put off by this. The company has a long trading history (it was the building products division of conglomerate Hanson back in the day) and it’s a decent size, with a market cap of about £450m. Furthermore, it looks to be a bargain buy.

A big show of confidence

Forterra (LSE: FORT) announced this week that Woodford has taken a notifiable stake in the company. In one day’s dealing last Friday his holding crossed the disclosable thresholds of 5%, 10%, 11%, 12%, 13%, 14%, 15% and 16%. By the end of the day, he owned over 33m shares — 16.7% of Forterra.

Woodford’s £70m investment is a big show of confidence in one of the leading manufacturers of building products for the UK building and construction industry. It follows Forterra’s maiden annual results as a listed company, which were released last month. The results were in line with expectations and management said that “2017 has started well, building on the momentum seen in the second half of 2016”.

The City consensus earnings forecast for the current year is for growth of 8%, taking earnings per share (EPS) to 23.2p, giving a price-to-earnings (P/E) ratio of 9.9 at a share price of 230p. The P/E is below the value threshold of 10 and a further advance in EPS forecast for next year drops it to 9. Meanwhile, a prospective dividend yield of 3.9%, rising to 4.3%, only adds to the stock’s value credentials.

Branded business parks

While Forterra is a new investment for Woodford, Sirius Real Estate (LSE: DRX) is an existing holding that he’s just pumped more cash into. This leading operator of branded business parks in Germany has a similar market cap to Forterra, being £470m at a share price of 53.5p.

Sirius notified the market this week that Woodford has increased his holding in the company from 38.3m shares to 44.9m. The purchase gives him a 5.1% stake valued at £24m, and follows a trading statement from the company earlier this month ahead of annual results scheduled for late June.

Sirius said the results are set to be in line with expectations. The City consensus is for EPS of 3.75p, giving a P/E of 14.3, which falls to 12.9 next year on forecasts of 11% EPS growth. The rating is rather higher than Forterra’s — but still reasonable — and the trade-off is that Sirius has a higher prospective yield of 4.8%, rising to 5.2%.

I can see why Woodford’s keen on both stocks and their valuations suggest now could be a good time to buy them.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »